2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Poster Session

[P20] Poster Session 20　Translational Research/Clinical Pharmacology（Basic science, Biomarker）

[P20-9] Eribulin for breast cancer cells with resistance to endocrine therapy promotes re-expression of estrogen receptor

○Wataru Goto, Shinichiro Kashiwagi, Misato Fujioka, Koji Takada, Yuka Asano, Tamami Morisaki, Tsutomu Takashima, Kosei Hirakawa, Masaichi Ohira (Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password